Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
RSC Advances|July 28, 2026
Flavonol tri- and tetraglycosides from Albizia guachapele Baker: isolation and biological evaluationMahmoud Sallam, Ahmed M Metwaly, Fatma G Amin, et al.
Archiv Der Pharmazie|November 16, 2020
N-Substituted-4-phenylphthalazin-1-amine-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studiesKhaled El-Adl, Mohamed-Kamal Ibrahim, Fathalla Khedr, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 17, 2025
Identification of Potential FDA-Approved Inhibitors of SARS-CoV-2 Helicase Through a Multistep In silico Approach: A Promising Prospect for COVID-19 TreatmentIbrahim H Eissa, Eslam B Elkaeed, Alaa Elwan, et al.
Archiv Der Pharmazie|July 13, 2022
New [1,2,4]triazolo[4,3-c]quinazoline derivatives as vascular endothelial growth factor receptor-2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluationAhmed E Azab, Mohamed S Alesawy, Wagdy M Eldehna, et al.
Molecules (Basel, Switzerland)|November 13, 2021
In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT StudiesMohamed S Alesawy, Eslam B Elkaeed, Aisha A Alsfouk, et al.
Bioorganic Chemistry|September 14, 2020
Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducersEslam M Abbass, Ali Kh Khalil, Mohamed M Mohamed, et al.
Archiv Der Pharmazie|October 10, 2019
Benzoxazole/benzothiazole-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluationsAbdel-Ghany A El-Helby, Helmy Sakr, Ibrahim H Eissa, et al.
Antiviral Therapy|December 6, 2024
Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase in silico approachAhmed M Metwaly, Eslam B Elkaeed, Aisha A Alsfouk, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 13, 2017
Design and Discovery of Novel Quinoxaline Derivatives as Dual DNA Intercalators and Topoisomerase II InhibitorsIbrahim H Eissa, Abeer M El-Naggar, Nour E A Abd El-Sattar, et al.
Molecules (Basel, Switzerland)|March 28, 2024
Chemistry and Pharmacology of Delta-8-TetrahydrocannabinolMaged S Abdel-Kader, Mohamed M Radwan, Ahmed M Metwaly, et al.
Pageof 17